Explore the Data and Appropriate Patient for Kisunla™

Gain knowledge that can help you take action in your own practice. Attend a live discussion about the recent efficacy and safety findings of Kisunla in patients with evidence of amyloid beta pathology and either mild cognitive impairment (MCI) or mild dementia stage of Alzheimer's disease.